ERBB2 and ductal breast carcinoma in situ: Linking the interobserver variability data to IHC stains demonstrated that almost all non‐high‐grade DCIS lesions according to the majority opinion were ER positive (100%) and HER2 negative (89%), whereas 55% of high‐grade DCIS lesions were ER negative and/or HER2 positive (62%).